LLY compared with ARWR: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ARWRArrowhead Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ARWRArrowhead Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ARWR

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±8.5%▼−2.99%×0.35

Q2 FY26±7.3%▼−6.75%×0.93

= impliedLLY realized, solidARWR realized, hatchedOne scale, both sides: full bar = 24%× = |realized| ÷ impliedSource: market data

Q1 FY26

±11.4%

▼−0.19%

×0.02

Nov 26 '25±13.6%▲+23.34%×1.71

LLYELI Lilly & Co

1,412.87▲+2.85%· post 1,417.05

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ARWRArrowhead Pharmaceuticals, Inc.

60.490.00%· post 59.64

ClosedOct 30 '26

Mkt cap$8.5BRevenue$75MQ3 FY26Revenue$829MFY25

Compare

ClosedOct 30 '26

LLYELI Lilly & Co

ARWRArrowhead Pharmaceuticals, Inc.

1,412.87▲+2.85%post 1,417.05

Price

60.490.00%post 59.64

$1.3T

Mkt cap

$8.5B

Q3 FY26$24.4B

Revenue

$75MQ3 FY26

FY25$65.2B

Revenue

$829MFY25

LLY1,412.87▲+2.85%vsARWR60.490.00%ClosedOct 30 '26